RAPID DETECTION OF VIABLE MICROORGANISMS
NanoLogix is a biotechnology company specializing in live cell, rapid diagnostics. Our kits are simple and reliable rapid test solutions that detect viable bacteria and other microorganisms 4x – 12x faster than traditional Petri culture technology, and more cost effectively than PCR Protocol.
Stock Symbol: NNLX.pk
MRSA 4x Faster
Jonathan Faro MD, Ph.D at the University of Texas Health Science Center — test results for MRSA
COMPANY UPDATES
January 12, 2012: NanoLogix Joins WHO StopTB Partnership
NanoLogix is pleased to announce it has been accepted as a member to the World Health Organization’s Stop TB Partnership. The organization consists of nearly 1000 partner members who are a collective force that is transforming the fight against tuberculosis in more than 100 countries. They include international and technical organizations, government programs, research and funding agencies, foundations, NGOs, civil society and community groups and the private sector. More information on NanoLogix membership in the StopTB Partnership can be found at http://www.stoptb.org/partners/partner_profile2.asp?PID=69342.
NANOLOGIX NEWS
1.10.12 MedCity News: NanoLogix readies FDA applications for rapid bacteria tests Read more>>
12.19.11 Homeland Security Today: DHS Emerging Technologies: The 9/11 Generation Comes of Age Read more>>
12.4.11 The Vindicator: Biotech Company Finds New Home In Hubbard Read more>>
11.11.11 Food Technology: Nanotechnology Aids Development of Pathogen Biosensors Read more>>
11.8.11 WFMJ.com: NanoLogix Test Detects TB Much Faster Read more>>